Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minori Baba

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bio-Protocol|April 27, 2026
A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer CellsNobuhiro Kubo, Minori Baba, Yuko Suzuki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodiesNobuhiro Kubo, Minori Baba, Chansu Shin, et al.
Molecular Medicine Reports|July 11, 2025
Chimeric PD‑1 receptor redirects primary T cells against childhood solid tumors but not to PD‑1 ligand‑positive CD80‑coexpressing cellsChansu Shin, Masaru Imamura, Yasushi Kasahara, et al.
Translational Oncology|August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcomaYudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2026
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept studyTomohiro Miyazaki, Yudai Murayama, Naoki Oike, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bio-Protocol|April 27, 2026
A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer CellsNobuhiro Kubo, Minori Baba, Yuko Suzuki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodiesNobuhiro Kubo, Minori Baba, Chansu Shin, et al.
Molecular Medicine Reports|July 11, 2025
Chimeric PD‑1 receptor redirects primary T cells against childhood solid tumors but not to PD‑1 ligand‑positive CD80‑coexpressing cellsChansu Shin, Masaru Imamura, Yasushi Kasahara, et al.
Translational Oncology|August 23, 2022
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcomaYudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2026
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept studyTomohiro Miyazaki, Yudai Murayama, Naoki Oike, et al.
Pageof 1